 CAMBRIDGE, Mass. BEIJING--BUSINESS WIRE--- BGNE BGNE--BeiGenes ALPINE trial of BRUKINSA zanubrutinib versus ibrutinib in chronic lymphocytic leukemia will be featured in EHA2021 Presidential Symposium. 